Yang He Tang (Yang Heartening Decoction)

Actions

Indications

Western Uses:

• What is Yang He Tang used for in modern practice?

  In modern practice Yang He Tang is referenced for deep, cold-type musculoskeletal and soft-tissue conditions that fit its yin-type pattern. Practitioners have traditionally applied it to conditions such as cold-type joint pain and stiffness (including presentations resembling ankylosing spondylitis and osteoarthritis), chronic cold subcutaneous nodules or lymphadenitis, and — historically, before antibiotics — deep-seated bone and joint infection such as skeletal tuberculosis, where the lesion presents cold, pale, and slow rather than hot and acute.

  These biomedical correlates are offered as a reference to the formula’s traditional use, not as a claim that it treats any disease. Some contemporary trials and laboratory studies (see research) have also explored it as an adjunct in oncology contexts under the same warming-yang theory, but that use is exploratory and always alongside, never instead of, conventional medical care. Any use for a diagnosed condition belongs with a qualified practitioner.

  Source: traditional-use correlates summarized from Bensky & Barolet, Formulas & Strategies; reference only, not a treatment claim.

Originally Appeared In:

• Complete Collection of Patterns and Treatments in External Medicine (Wai Ke Zheng Zhi Quan Sheng Ji)

Notes:

• How is Yang He Tang different from related formulas, and how is it modified?

  Yang He Tang is distinguished by treating cold, deficient (yin-type) swellings — the opposite pattern from formulas that clear heat-toxin sores.

  • vs Si Miao Yong An Tang: Si Miao Yong An Tang clears heat and toxin for hot, yang-type sores and abscesses (e.g. red, swollen, painful); Yang He Tang treats the cold, pale, yin-type opposite. The two patterns should never be confused.
  • vs Yang He Jie Ning Wan: a related pill-form formula built on the same warm-yang, dissolve-cold-phlegm strategy, generally considered gentler and better suited to long-term use for chronic, slow-forming nodules.
  • vs Du Huo Ji Sheng Tang: Du Huo Ji Sheng Tang addresses chronic wind-damp Bi (painful obstruction) with Liver/Kidney and qi/blood deficiency and widespread joint stiffness, without the phlegm-nodule, cold-sore focus that defines Yang He Tang.

  Common modifications: add Ru Xiang and Mo Yao to invigorate blood and relieve pain when a nodule or swelling is firm and painful; add Xia Ku Cao to strengthen phlegm-nodule dispersal. Where Lu Jiao Jiao (deer antler glue) is unavailable, Lu Jiao Shuang (degelatinized antler shavings) or Lu Jiao (deer horn) are common practical substitutes, typically at a higher dose since they are less concentrated than the glue.

  Source: Bensky & Barolet, Formulas & Strategies (formula comparisons and modifications).

Clinical Studies & Research:

• Is there modern research on Yang He Tang?

  Yes — modern research includes randomized clinical trials in musculoskeletal and oncology-adjunct contexts, plus mechanistic/preclinical work. A randomized controlled trial of modified Yang He Tang in ankylosing spondylitis found symptom improvement comparable to a celecoxib-sulfasalazine control, with fewer adverse effects in the herbal group. A separate randomized, placebo-controlled trial tested Yang He Tang as an add-on to neo-adjuvant chemotherapy in breast cancer, examining pathological response and immune-inflammatory markers. Preclinical work has also explored a mitochondrial-autophagy mechanism (AMPK-SIRT3 pathway) for cartilage protection in an osteoarthritis animal model.

  • Ankylosing spondylitis (clinical RCT): modified Yang He Tang vs. celecoxib-sulfasalazine, ASAS20 response and safety compared (PMID 29735967).
  • Breast cancer, neo-adjuvant chemotherapy adjunct (clinical RCT): randomized, placebo-controlled trial evaluating pathological response and immune-inflammatory markers (PMID 35451408).
  • Osteoarthritis (preclinical, mechanism): AMPK-SIRT3-mediated mitochondrial autophagy and reduced chondrocyte apoptosis in an animal model (PMID 39746407).

  Sources: PubMed 29735967; PubMed 35451408; PubMed 39746407. Research context, not a therapeutic claim; the oncology-adjunct trial studied Yang He Tang alongside, not in place of, conventional chemotherapy.